A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Patients With Cold Agglutinin Disease (CAD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05096403 |
|
Recruitment Status :
Recruiting
First Posted : October 27, 2021
Last Update Posted : March 22, 2022
|
Sponsor:
Swedish Orphan Biovitrum
Information provided by (Responsible Party):
Swedish Orphan Biovitrum
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | May 2024 |
| Estimated Study Completion Date : | June 2024 |